Page last updated: 2024-10-27

gabexate and Indigestion

gabexate has been researched along with Indigestion in 3 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"The aim of the present study was to examine the potential efficacy of camostat mesilate, a protease inhibitor, against dyspepsia associated with non-alcoholic mild pancreatic disease."9.14Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease. ( Inami, K; Kubokawa, Y; Matsumura, Y; Sai, JK; Suyama, M; Watanabe, S, 2010)
"Camostat mesilate is superior to famotidine for relieving epigastralgia in patients with functional dyspepsia."9.12Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective? ( Ashizawa, N; Hashimoto, T; Imaoka, T; Kinoshita, Y; Miyake, T; Shizuku, T, 2006)
"The aims of the study are to clarify the pathophysiological differences among early chronic pancreatitis (ECP), functional dyspepsia with pancreatic (FD-P) enzyme abnormalities and FD patients and to determine whether camostat mesilate, pancrelipase, and rabeprazole triple therapy improve FD symptoms in the ECP patients and FD-P patients in cross-over way."7.91Camostat Mesilate, Pancrelipase, and Rabeprazole Combination Therapy Improves Epigastric Pain in Early Chronic Pancreatitis and Functional Dyspepsia with Pancreatic Enzyme Abnormalities. ( Agawa, S; Futagami, S; Gudis, K; Higuchi, K; Iwakiri, K; Kaneko, K; Kawamoto, C; Kodaka, Y; Murakami, M; Sakasegawa, N; Ueki, N; Wakabayashi, M; Yamawaki, H, 2019)
"The aim of the present study was to examine the potential efficacy of camostat mesilate, a protease inhibitor, against dyspepsia associated with non-alcoholic mild pancreatic disease."5.14Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease. ( Inami, K; Kubokawa, Y; Matsumura, Y; Sai, JK; Suyama, M; Watanabe, S, 2010)
"Camostat mesilate is superior to famotidine for relieving epigastralgia in patients with functional dyspepsia."5.12Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective? ( Ashizawa, N; Hashimoto, T; Imaoka, T; Kinoshita, Y; Miyake, T; Shizuku, T, 2006)
"The aims of the study are to clarify the pathophysiological differences among early chronic pancreatitis (ECP), functional dyspepsia with pancreatic (FD-P) enzyme abnormalities and FD patients and to determine whether camostat mesilate, pancrelipase, and rabeprazole triple therapy improve FD symptoms in the ECP patients and FD-P patients in cross-over way."3.91Camostat Mesilate, Pancrelipase, and Rabeprazole Combination Therapy Improves Epigastric Pain in Early Chronic Pancreatitis and Functional Dyspepsia with Pancreatic Enzyme Abnormalities. ( Agawa, S; Futagami, S; Gudis, K; Higuchi, K; Iwakiri, K; Kaneko, K; Kawamoto, C; Kodaka, Y; Murakami, M; Sakasegawa, N; Ueki, N; Wakabayashi, M; Yamawaki, H, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamawaki, H1
Futagami, S1
Kaneko, K1
Agawa, S1
Higuchi, K1
Murakami, M1
Wakabayashi, M1
Sakasegawa, N1
Kodaka, Y1
Ueki, N1
Gudis, K1
Kawamoto, C1
Iwakiri, K1
Sai, JK1
Suyama, M1
Kubokawa, Y1
Matsumura, Y1
Inami, K1
Watanabe, S1
Ashizawa, N1
Hashimoto, T1
Miyake, T1
Shizuku, T1
Imaoka, T1
Kinoshita, Y1

Trials

2 trials available for gabexate and Indigestion

ArticleYear
Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease.
    Journal of gastroenterology, 2010, Volume: 45, Issue:3

    Topics: Abdominal Pain; Adult; Aged; Dyspepsia; Endosonography; Esters; Female; Gabexate; Guanidines; Humans

2010
Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective?
    Journal of gastroenterology and hepatology, 2006, Volume: 21, Issue:4

    Topics: Anti-Ulcer Agents; Dyspepsia; Esters; Famotidine; Female; Gabexate; Guanidines; Humans; Japan; Male;

2006

Other Studies

1 other study available for gabexate and Indigestion

ArticleYear
Camostat Mesilate, Pancrelipase, and Rabeprazole Combination Therapy Improves Epigastric Pain in Early Chronic Pancreatitis and Functional Dyspepsia with Pancreatic Enzyme Abnormalities.
    Digestion, 2019, Volume: 99, Issue:4

    Topics: Abdominal Pain; Aged; Benzamides; Drug Therapy, Combination; Dyspepsia; Esters; Female; Gabexate; Ga

2019